Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Loral/Gammasonics

This article was originally published in The Gray Sheet

Executive Summary

Defense technology company Loral enters a definitive agreement with Siemens Medical Systems to acquire Siemens Gammasonics. Gammasonics, with about 100 employees, is focused on the "development of software and related products" for picture archiving and communication systems (PACS). Terms of the deal were not disclosed. Gammasonics will remain located in Hoffman Estates, Illinois, and will be renamed Loral Medical Imaging Systems. Gammasonics has provided software as a subcontractor to Loral for its Medical Diagnostic Imaging System contract for U.S. military hospitals. MDIS, which Loral eventually wants to market in the private sector, "electronically digitalizes, processes, stores and distributes" radiological images, Loral says

You may also be interested in...



New US FDA Commissioner Stephen Hahn Heads to White Oak Under Vaping Cloud

Bipartisan Senate confirmation vote comes despite concerns about Stephen Hahn's non-answers to e-cigarette regulation questions.

Drug Pricing Policies Attached To Surprise Medical Billing Legislation

Strategy could improve chances of passage, offer politicians the opportunity to show the public they are doing something to address drug pricing.

US Government Drug Pricing ‘Negotiation:’ Where We Go From Here

House passes Democratic bill authorizing the federal government to negotiate drug prices in Medicare. While the exercise has sharpened the debate over how prices feed innovation, the underlying policy stands little chance of being enacted without a Democratic wave in the next election. Our table highlights the key provisions of HR 3 and other pending pricing legislation.

UsernamePublicRestriction

Register

MT002770

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel